Cerus reported $-10361000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Atrion ATRI:US 12.8M 117K
Cerulean Pharma CERU:US $ -12.66M 3.51M
Cerus CERS:US $ -10.36M 3.26M
Cytori Therapeutics CYTX:US $ -3.39M 0.91M
GRIFOLS GRF:SM € 330.18M 44.07M
Haemonetics HAE:US $ 55.92M 5.36M
Neogen NEOG:US $ 18.3M 9.13M
Nuvasive NUVA:US $ 35.78M 24.04M
Quidel QDEL:US $ 294.63M 255.81M
Sientra SIEN:US $ -10.66M 2.22M
Staar Surgical STAA:US $ 8.76M 2.78M